Case Report | Open Access
Meera Yogarajah, Chidozie Charles Agu, Bhradeev Sivasambu, Mark A. Mittler, "HbSC Disease and Spontaneous Epidural Hematoma with Kernohan’s Notch Phenomena", Case Reports in Hematology, vol. 2015, Article ID 470873, 3 pages, 2015. https://doi.org/10.1155/2015/470873
HbSC Disease and Spontaneous Epidural Hematoma with Kernohan’s Notch Phenomena
Spontaneous (nontraumatic) acute epidural hematoma is a rare and poorly understood complication of sickle cell disease. A 19-year-old African American male with hemoglobin SC disease (HbSC) presented with generalized body aches and was managed for acute painful crisis. During his hospital stay he developed rapid deterioration of his mental status and computed topography revealed a spontaneous massive epidural hematoma with mass effect and midline shift with Kernohan’s notch phenomena for which urgent craniotomy and evacuation was done. We report the first case of HbSC disease associated with catastrophic epidural hematoma progressing to transtentorial herniation and Kernohan’s notch phenomena within few hours with rapid clinical deterioration. The etiopathogenesis and the rare presentation are discussed in detail in this case report.
Sickle cell disease is associated with cerebrovascular complications and the risk varies with the genotype. The Cooperative Study of Sickle Cell Disease revealed a significantly high incidence of cerebrovascular events in HbSS disease at 0.61 per 100 patient-years with corresponding low values of 0.15, 0.09, and 0.08, respectively, for HbSC, HbS-beta (+) thalassemia, and HbS beta (0) thalassemia . Intracranial hemorrhage constitutes one-third of the cerebrovascular event in sickle cell disease with higher incidence noted in young adults as opposed to cerebral infarction which occurs more in children. Subarachnoid, intraparenchymal, intraventricular, or a combination of these hemorrhages is commonly associated with sickle cell disease. Spontaneous epidural hematoma is a rare poorly understood complication of sickle cell disease.
2. Case Presentation
A “19-year-old” African American male with HbSC disease presented with generalized body aches for “4 hours’ duration” which did not respond to ibuprofen which he usually uses for pain. He denied any other systemic complaints and was unable to identify any trigger factors for his painful crisis. He had multiple inpatient admissions in the past for painful crisis but did not have any history of previous stroke, acute chest syndrome, or other sickle cell disease associated complications. On examination patient was afebrile and hemodynamically stable with a blood pressure of 121/83 mmhg and pulse rate of 63/min. Systemic examination was unrevealing. Initial labs revealed white blood cell count of 10.3 k/uL, hemoglobin of 12.7 g/dL, hematocrit of 39.4%, and platelet count of 177 k/uL. The electrolytes, renal function test, and liver enzymes were normal except for mild hyperbilirubinemia of 2.2 mg/dL (0.3–1.2). His coagulation panel was normal. Patient was managed for acute vasoocclusive crisis with intravenous hydration and opioids optimized according to the pain scale. Patient continued to have generalized body aches during the hospital stay and his opioids were increased after which he was comfortable. On the second day of admission patient suddenly became diaphoretic and unresponsive. Naloxone was administered with improvement in mentation; however, in 3 hours patient again became drowsy and was only responding to deep painful stimuli. Emergent computed topography of the head revealed large 3.6 × 9.7 cm right acute epidural hematoma with mass effect on the adjacent sulci and right lateral ventricle with 1.6 cm right-to-left midline shift (Figure 1). There was no history of trauma prior to hospitalization and he did not sustain any trauma during the hospital stay. Patient underwent urgent craniotomy and evacuation of the epidural hematoma (Figure 2). There was no evidence of skull infarction and the bony margins were regular and not thickened with no periosteal elevation and a bleeding vessel was not identified. On recovery patient had mild ipsilateral hemiparesis and postoperative imaging revealed Kernohan’s notch phenomena (Figures 3, 4, and 5).
Epidural hematoma commonly occurs secondary to trauma with associated skull fracture and arterial injury in 85% of the cases [2, 3] and the damage to the dural sinuses in 15% of the cases . Spontaneous epidural hematoma by itself is rare. Spontaneous epidural hematoma secondary to sickle cell disease has been scarcely described in the literature and the mechanism still remains obscure. Skull infarction causing periosteal elevation and disrupting the cortical bone and eventually bleeding into the epidural place is one of the proposed mechanisms . Another postulation is inadequate venous drainage causing edema and triggering bleeding due to rupture of the veins . Though extra medullary hematopoiesis commonly occurs in long bones, it rarely occurs in the calvarium and during acute hemolytic crisis expansion of the skull bone due to hematopoiesis can disrupt the bony margins and predispose to rupture of the vessels and bleeding . The pathogenesis of bleeding in our patient was not identified as there was no evidence of bone infarction and no bleeding vessel was noted. The possible explanation as described in the literature by Dahdaleh et al. would be disruption of the cortical bone margin occurring at a microscopic level . Low steady-state hemoglobin and high steady-state leucocyte count have been associated with increased propensity for hemorrhagic stroke in sickle cell disease . However our patient did not have any of these risk factors. Other postulated risk factors include previous ischemic stroke, moyamoya lesions , recent hypertension, transfusion, and treatment with steroids . Spontaneous epidural hematoma has also been reported with infections like sinusitis and epidural abscess, coagulopathy, chronic kidney disease and hemodialysis, metastasis to the dura, and vascular malformations [9, 10].
The classical lucid interval that occurs in traumatic epidural hematoma due to concussion of the brain does not occur in spontaneous (nontraumatic) epidural hematoma. Headache is the commonest clinical manifestation mostly reported secondary to epidural hematoma associated with sickle cell disease; however, our patient only complained of generalized worsening body aches and the opioid dose was increased which likely masked the initial warning signs of epidural hematoma.
The literature review revealed few reported cases of epidural hematoma in association with sickle cell disease which occurred predominantly with HbSS genotype [4–6, 10]. HbSC disease is less commonly associated with cerebrovascular accidents and there has been only one reported case of epidural hematoma associated with HbSC disease . The etiology of the epidural hematoma in this patient was skull infarction and patient had a small adjacent epidural hematoma which was managed conservatively. We report the first case of HbSC disease associated with catastrophic epidural hematoma progressing to transtentorial herniation and Kernohan’s notch phenomena within few hours with rapid clinical deterioration.
Sudden unresponsiveness in a sickle cell disease patient should prompt the physicians on the possibility of a cerebrovascular complication. Response to Naloxone may be subjective and usually most of these patients are on high doses of opioids to control pain which might mask the initial clinical symptoms and thus may warrant neuroimaging irrespective of the transient improvement of mentation to prevent major sequelae.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
- K. Ohene-Frempong, S. J. Weiner, L. A. Sleeper et al., “Cerebrovascular accidents in sickle cell disease: rates and risk factors,” Blood, vol. 91, no. 1, pp. 288–294, 1998.
- S. Mayer and L. Rowland, “Head injury,” in Merritt's Neurology, L. Rowland, Ed., p. 401, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2000.
- M. R. Bullock, R. Chesnut, J. Ghajar et al., “Surgical management of acute epidural hematomas,” Neurosurgery, vol. 58, supplement 3, pp. S7–S15, 2006.
- L. M. S. Resar, M. M. Oliva, and J. F. Casella, “Skull infarction and epidural hematomas in a patient with sickle cell anemia,” Journal of Pediatric Hematology/Oncology, vol. 18, no. 4, pp. 413–415, 1996.
- J.-P. Kalala Okito, O. Van Damme, L. Calliauw, K. Al Moutaery, and F. Servadei, “Are spontaneous epidural haematomas a rare complication in sickle cell disease? A report of two new cases,” Acta Neurochirurgica, vol. 146, no. 4, pp. 407–410, 2004.
- N. S. Dahdaleh, T. E. Lindley, P. A. Kirby, H. Oya, and M. A. Howard III, “A ‘neurosurgical crisis’ of sickle cell disease: case report,” Journal of Neurosurgery: Pediatrics, vol. 4, no. 6, pp. 532–535, 2009.
- D. Powars, R. J. Adams, F. T. Nichols, P. Milner, S. Charache, and S. Sarnaik, “Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia,” Journal of the Association for Academic Minority Physicians, vol. 1, no. 3, pp. 79–82, 1990.
- J. J. Strouse, M. L. Hulbert, M. R. DeBaun, L. C. Jordan, and J. F. Casella, “Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids,” Pediatrics, vol. 118, no. 5, pp. 1916–1924, 2006.
- J. I. McIver, B. W. Scheithauer, C. H. Rydberg, and J. L. D. Atkinson, “Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report,” Neurosurgery, vol. 49, no. 2, pp. 447–449, 2001.
- W. H. Ng, T. T. Yeo, and W. T. Seow, “Non-traumatic spontaneous acute epidural haematoma—report of two cases and review of the literature,” Journal of Clinical Neuroscience, vol. 11, no. 7, pp. 791–793, 2004.
- S. Arends, J. A. Coebergh, J. L. Kerkhoffs, A. Van Gils, and H. Koppen, “Severe unilateral headache caused by skull bone infarction with epidural haematoma in a patient with sickle cell disease,” Cephalalgia, vol. 31, no. 12, pp. 1325–1328, 2011.
Copyright © 2015 Meera Yogarajah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.